Viewing StudyNCT03689244



Ignite Creation Date: 2024-05-06 @ 12:09 PM
Last Modification Date: 2024-10-26 @ 12:55 PM
Study NCT ID: NCT03689244
Status: TERMINATED
Last Update Posted: 2024-06-21
First Post: 2018-09-27

Brief Title: A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or PersistentRecurrent After Surgery andor Interventional Treatment
Sponsor:
Organization: Actelion

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 128
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: